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Abstract: Non-glucose biomarker-DNA oxidative damage biomarker 8-hydroxy-2′-
deoxyguanosine (8-OHdG) has been successfully detected using a smartphone-enabled glucose 
meter. Through a series of immune reactions and enzymatic reactions on a solid lateral flow 
platform, 8-OHdG concentration has been converted to a relative amount of glucose, and 
therefore can be detected by conventional glucose meter directly. The device was able to detect 
8-OHdG concentrations in phosphate buffer saline as low as 1.73 ng mL−1 with a dynamic range 
of 1–200 ng mL−1. Considering the inherent advantages of the personal glucose meter, the dem-
onstration of this device, therefore, should provide new opportunities for the monitoring of a 
wide range of biomarkers and various target analytes in connection with different molecular 
recognition events.
Keywords: 8-OHdG, immunostrip, point-of-care, POCTs, biosensor, DNA oxidative damage
Introduction
In recent years, much effort has been devoted toward developing point-of-care (POC) 
devices.1–9 Among them, paper-based POC devices are a special category due to the 
advantages of being simple, rapid, on-site, and cost-effective; they have been widely 
used in home health care and medical testing,10–12 even environmental monitoring.13–15 
The lateral flow immunochromatographic assay, also called lateral flow test, is one of 
the simplest and most popular formats of paper-based POC devices and can be used 
to detect specific substances, including small molecules,15–18 large proteins,19–21 and 
even whole pathogens,10 in a sample by using an immunological reaction. However, 
most of these tests are based on qualitative colorimetry, which is not sufficient in 
many cases. To overcome this limitation, a number of devices capable of quantitative 
analysis have been developed.
As we know, medical devices for POC are very costly to develop and manufacture 
and are difficult to commercialize. As a result, few have been commercialized success-
fully. The blood glucose meter (BGM) is one of the most successfully commercialized 
diagnostic devices on the market,22,23 and it is widely used by millions of diabetes 
patients to monitor their blood glucose levels every day because of its low cost, com-
pact size, simple operation, and reliable quantitative results.2 The successful launch of 
US Food and Drug Administration (FDA)-approved smartphone-enabled BGMs, which 
enable the wireless transmission of reminders, test results, and data analysis through 
smartphone apps, will attract an even larger number of users.24 Generally, a glucose 
meter is capable of detecting glucose as the unique target. Recently, many groups 
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have reported methods establishing a direct relationship 
between the concentrations of the targets in the samples and 
the glucose detected by a BGM, enabling a number of non-
glucose targets to be detected quantitatively.2,25,26 However, 
most of these methods included much liquid handling, such 
as adding and mixing solution, which should be avoided as 
much as possible to ensure ease of use. Conversely, a lateral 
flow device, as mentioned previously, is supposed to replace 
most of the manual solution addition and mixing involved 
in the above-mentioned methods.
Here, we describe a novel design that combines the tradi-
tional lateral flow strip with a commercialized smartphone-
enabled BGM (iBGStar® Blood Glucose Monitoring System) 
for portable and quantitative detection of a non-glucose target. 
The concept is demonstrated by using an oxidative DNA 
damage biomarker, 8-hydroxy-2′-deoxyguanosine (8-OHdG). 
The basic design of the device is adapted from our previously 
reported colorimetric visual detection platform17 based on a 
gold nanoparticles (AuNPs)-based competitive immunoassay. 
However, visual detection can provide only qualitative and 
semiquantitative results. Thus, to enable quantitative analysis, 
we establish a novel method that transforms the detection of 
the target to the detection of an enzyme invertase. The enzyme 
converts sucrose into glucose for BGM readout.
Materials and methods
Design and detection mechanism
As shown in Figure 1, the test strip is composed of five 
components, preloaded with different reagents and pasted 
onto a plastic backing plate. The sample pad pretreated with 
buffer (50 mM borate buffer, 1% bovine serum albumin 
[BSA], and 0.2% Tween 20) is where the strip contacts the 
liquid sample. Two conjugation pads, which are composed 
of glass fiber material, contain AuNPs-labeled mouse anti-8-
hydroxyguanosine antibody (Ab; has equal binding affinity to 
8-OHdG and 8-hydroxyguanosine) and 8-hydroxyguanosine–
invertase conjugates, respectively. Next to the conjugation 
pad II is a flow membrane, which is made of nitrocellulose. 
There are two reaction zones on this membrane, which are 
called test line and control line. A goat anti-mouse immuno-
globulin G (IgG) Ab is used as the test line capture reagent, 
whereas a goat anti-invertase Ab is used as the control line 
capture reagent. The sample moves along the strip due to 
capillary action and finally gets collected by the last part 
known as the absorption pad.
To realize non-glucose target detection using a BGM, 
the relationship between target recognition and glucose 
generation must be established. In our design, as illustrated 
in Figure 1, the detection is based on two steps: the first step 
is that of competitive-type immunoreactions in the lateral 
flow strip (Figure 2A–D) and the second step contains an 
enzymatic reaction, which converts sucrose into detectable 
glucose for measurement by the smartphone-based BGMs 
(Figure 2E–G).
Upon target introduction (Figure 2A), the target moves 
along the strip due to capillary force and rehydrates conjuga-
tion pads I and II (Figure 2B). 8-OHdG in the sample solution 
and invertase-conjugated 8-hydroxyguanosine compete to 
bind to the Ab from the conjugation pad I. After that, the 
invertase that binds to AuNPs is captured by the test line 
(Figure 2C), whereas the free invertase is captured by the 
control line (Figure 2D). Ideally, the higher the concentration 
????????????????
??????
???????????????????????????????????????
????????????????? ?????????????????
?????????? ?????????????????
?????????????????? ????????? ????????????
???????????????????????????????
??????????????
Figure 1 Design of a test strip for quantitative detection of 8-Ohdg.
Abbreviations: ab, antibody; auNPs, gold nanoparticles; 8-Ohdg, 8-hydroxy-2′-deoxyguanosine; Igg, immunoglobulin g.
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of 8-OHdG in the sample solution is the less invertase 
captured on the test line and the more invertase captured 
on the control line. Following the first step (~10 min), the 
test (3 mm) and control (3 mm) lines are cut by scissors and 
put on a hydrophobic plate (Figure 2E). Twenty microli-
ters of 0.5 M sucrose solution is added on top of each line 
(Figure 2F). After a certain period of time, the invertase fixed 
on each line catalyzes the hydrolysis of sucrose to produce 
a specific amount of glucose for quantitative readout by the 
smartphone-based BGMs (Figure 2G).
reagents
BSA, invertase from baker’s yeast (Saccharomyces cerevi-
siae), sucrose, gold chloride trihydrate, sodium borohydride 
??????? ???????
??????????????
?
?
?
?
?
?
?
???????????????? ???????????????????????????????????????
?????? ????????????????? ?????????????????
Figure 2 Mechanism for non-glucose target (8-Ohdg) detection by a smartphone-based BgM.
Notes: (A) sample loading, (B) immunoreactions and migration, (C) capture of antibody from the first conjugation pad on the test zone, (D) capturing the rest enzyme 
on the control zone, (E) cut the test and control zones and put them on a hydrophobic plate, (F) add the sucrose solution (20 µl) on top of each zone, (G) after a specific 
period of time, measure the concentration of glucose produced on each zone by iBgstar Blood glucose Monitoring system.
Abbreviations: ab, antibody; auNPs, gold nanoparticles; BgM, blood glucose meter; 8-Ohdg, 8-hydroxy-2′-deoxyguanosine; Igg, immunoglobulin.
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(NaBH
4
), sodium periodate (NaIO
4
), ethylene glycol, 
potassium carbonate (K
2
CO
3
), boric acid, sodium chloride, 
and sodium phosphate were received from Sigma-Aldrich 
(St Louis, MO, USA). Trehalose, phosphate buffer saline 
(PBS, 1X, pH =7.4), and trisodium citrate dihydrate were 
purchased from VWR (West Chester, PA, USA). Tween 20 
was obtained from Fisher Scientific (Fairlawn, NJ, USA). 
Plastic backing, nitrocellulose membrane, absorbing pad, 
and cellulose paper were acquired from Millipore (Billerica, 
MA, USA). 8-OHdG and 8-hydroxyguanosine were pur-
chased from Cayman Chemical (Ann Arbor, MI, USA). 
Mouse monoclonal antibodies to 8-hydroxyguanosine, 
polyclonal goat anti-mouse IgG, and polyclonal goat anti-
invertase IgG were purchased from Abcam (Cambridge, MA, 
USA). The iBGStar Blood Glucose Monitoring System and 
Blood Glucose Test Strips for iBGStar were obtained from 
Walgreens (Springfield, IL, USA).
synthesis of auNPs-labeled anti-8-
hydroxyguanosine ab conjugates for 
conjugation pad I
The AuNPs-labeled anti-8-hydroxyguanosine Ab conjugates 
were synthesized according to our previously published 
method.17 The Supplementary materials also include a detail 
instruction for the synthesis. For the conjugation, the AuNPs 
solution (~20 nm) was concentrated fivefold and the pH was 
adjusted to 8.5–9.0 with 0.1 M K
2
CO
3
 in advance for labeling. 
The Ab with optimal concentration (45 µL, 0.54 mg mL−1) 
was added to the AuNPs solution (560 µL, 5X) and stirred 
gently at room temperature for 1 h. The conjugate was sta-
bilized by adding 65 µL 10% BSA in 20 mM sodium borate 
for a final concentration of 1% and incubated for another 
20 min. Then the mixture was centrifuged for 15 min at 
7,000 rcf. The supernatant was discarded, and the pellet was 
resuspended in 600 µL 1% BSA/PBS. Following the same 
centrifugation step, the supernatant was removed and the soft 
sediment of conjugates was finally resuspended in 600 µL 
conjugation buffer, containing 20 mM sodium phosphate, 
0.25% Tween 20, 10% trehalose, and 5% BSA. The conjugate 
was stored at 4°C until required for use. Characterization of 
AuNP and its conjugation is documented in the Supplemen-
tary materials.
Preparation of 8-hydroxyguanosine–
invertase conjugates for conjugation pad II
8-hydroxyguanosine (0.8 mg) was dissolved in 800 µL 
1X PBS. The solution (1 mg mL−1) was mixed with NaIO
4
 
(200 µL, 50 mM) and the mixture was incubated for 1 h in 
the dark. The reaction was stopped by adding ethylene glycol 
(2.5 µL) for 5 min. Then the mixture (500 µL) was mixed 
with invertase (2.5 mL, 29 g L−1, pH =9.5, adjusted by K
2
CO
3
 
[50 g L−1]) by adding it dropwise under constant stirring and 
incubated for another 1 h. After that, NaBH
4
 (2 mL, 12 g L−1) 
was added and the mixture was incubated in the dark at 4°C 
overnight (12–16 h). Finally, the conjugates were dialyzed 
against 1X PBS and stored at −20°C.
Assembly of the lateral flow immuno 
strip
The goat anti-mouse IgG Ab (1 mg mL−1) was used as the test 
line capture reagent, whereas the goat anti-invertase IgG Ab 
(3.3 mg mL−1) was used as the control line capture reagent. 
These capture reagents were dispensed by the Linomat 5 
dispenser onto a nitrocellulose membrane as the test and 
control lines. The sample pad was pretreated with buffer 
(50 mM borate buffer, 1% BSA, and 0.2% Tween 20), then 
AuNPs-labeled anti-8-hydroxyguanosine Ab (20 µL) and 
8-hydroxyguanosine–invertase conjugates (20 µL) were 
dispensed by pipette onto glass fiber pads, which were called 
the conjugate pad I and II, respectively. After drying these 
membranes, the sample pad, conjugate pads, nitrocellulose 
membrane, and absorbent pad were pasted onto a plastic 
backing plate, which was already cut into 5-mm wide strips 
using a strip cutter. Then the strips were stored in a self-
sealing plastic bag until use.
Results and discussion
check the properties of 
8-hydroxyguanosine–invertase conjugates
One of the most important components in the design is 
8-hydroxyguanosine–invertase conjugates. This is synthe-
sized according to a well-established method.27 The method 
requires several steps of chemical reactions that might affect 
the structure and function of the enzyme to a certain extent. 
Thus, two aspects of the functions of the conjugates were 
examined before being used for conjugation pad II: enzy-
matic activity (invertase part) for glucose production and 
antigenic activity (8-hydroxyguanosine part) for competitive 
immunoreactions.
The enzymatic activity of the conjugates (invertase part) 
was tested by mixing 10 µL of conjugates solution with 50 µL 
of 0.5 M sucrose solution. The BGM readout of the modified 
invertase was 134±5 mg dL−1 (n=3) after 2 min, while that 
of the original invertase was 148±7 mg dL−1 (n=3), indicat-
ing that the modified invertase retains a high enzymatic 
activity after the chemical modifications. The antigenic 
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activity of the conjugates was tested through our previously 
published method.17 As illustrated in Figure 3, competitive 
type strips are designed for testing small molecules with 
single antigenic determinants (ie, 8-OHdG), which cannot 
bind to two antibodies simultaneously. Both 8-OHdG in the 
sample solution and 8-hydroxyguanosine on the test line 
compete to bind to the Ab from the conjugation pad. As a 
result, the intensity of the test line is inversely proportional 
to the concentration in the sample. Our previous publica-
tion has verified that 8-hydroxyguanosine–BSA conjugates 
maintain considerable Ab capturing capacity. In this study, 
we compare 8-hydroxyguanosine–invertase conjugates with 
8-hydroxyguanosine–BSA conjugates in terms of this capac-
ity (see test line in Figure 4). These two conjugates show no 
difference at both low (0 ng mL−1) and high (1,000 ng mL−1) 
8-OHdG sample loading, demonstrating the feasibility of the 
function of 8-hydroxyguanosine in the 8-hydroxyguanosine–
invertase conjugates for the following application.
Optimization of the amount of 
8-hydroxyguanosine–invertase conjugates 
used on conjugation pad II and of the 
time for enzymatic reaction
The amount of 8-hydroxyguanosine–invertase conjugates 
used on conjugation pad II played an important role in the 
performance of this detection system. We tested five con-
centrations of conjugates (original 14.5 mg mL−1, diluted 
5-fold, diluted 10-fold, diluted 20-fold, and diluted 30-fold) 
on conjugation pad II. Two concentration levels, PBS buffer 
(0 ng mL−1) and high concentration (50 ng mL−1), were 
prepared and applied to these five types of strips. After 
10 min, the test (3 mm) and control (3 mm) lines were cut by 
scissors and put on a hydrophobic plate. Twenty microliters of 
0.5 M sucrose solution was added on top of each line. After a 
certain period of time, the invertase fixed on each line cata-
lyzes the hydrolysis of sucrose to produce a specific amount 
of glucose for quantitative BGM readout. At the same time, 
the catalytic reaction time was also optimized. The readouts 
????????????????????? ???????????????
???????? ??????????? ????????????? ???????
??????????????????????
???????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????
Figure 3 Mechanism of competitive lateral flow immunoassay for 8-OHdG testing.
Abbreviations: ab, antibody; auNPs, gold nanoparticles; Bsa, bovine serum albumin; 8-Ohdg, 8-hydroxy-2′-deoxyguanosine.
????????????????????????????????????????????
????????????????????? ??????????????????????????????
??????????????????????????????????????????????????
????????????????????????????????
????????????????????????????????
Figure 4 The photographs of test strips based on two samples (0 and 1,000 ng ml−1).
Notes: Top row: 8-hydroxyguanosine–Bsa conjugates were used as the capture 
reagents on the test line; bottom row: 8-hydroxyguanosine–invertase conjugates 
were used as the capture reagents on the test line. left three columns: samples with 
a concentration of 0 ng ml−1; right three columns: samples with a concentration of 
1,000 ng ml−1.
Abbreviations: Bsa, bovine serum albumin; 8-Ohdg, 8-hydroxy-2′-deoxy-
guanosine; Igg, immunoglobulin g; PBs, phosphate buffer saline.
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of the BGM at 20 and 40 min time points were collected 
respectively, from which we found that 20 min is not enough 
for some low concentrations (diluted 10-fold, 20-fold, and 
30-fold). However, the relative readout ratio defined as
 
RRR =




Ratio
Readout of test line
Readout of control line
(50 ngmL )
(0 ngm
1
Ratio
Readout of test line
Readout of control line
−




L )1−  
was used to determine the efficiency of the strips to distin-
guish one concentration from another (Figure 5). As a result, 
20-fold diluted conjugates and 40-min reaction time were 
chosen for the following experiment.
Quantitative detection of 8-Ohdg  
by a BgM
Under the optimized conditions, a series of 8-OHdG solu-
tions with concentrations of 0, 1, 10, 50, 100, 200, and 
1,000 ng mL−1 in 1X PBS buffer were prepared and applied 
to the strips. After 10 min, the test (3 mm) and control (3 mm) 
lines were cut by scissors and put on a hydrophobic plate. 
Twenty microliters of 0.5 M sucrose solution was put on top 
of each line, and a smartphone-enabled BGM was used for 
readout after 40 min. As shown in Figure 6, the normalized 
readout ratio (NRR) defined as
 
NRR =




Ratio
Readout of test line
Readout of control line
(concentration [ngmL ])1
Ratio
Readout of test line
Readout of control li
−
ne
(blank [ngmL ])1



 −  
decreased when the concentration increased, which is 
consistent with the theory of the competitive format of 
detection. From this figure, we can see that NRR has no 
obvious change when the concentration is .200 ng mL−1. 
However, elevated concentrations of 8-OHdG from 0 to 
200 ng mL−1 lead to obviously decreased NRR. A dynamic 
range of 1–200 ng mL−1 can be obtained with R2=0.995, and 
as low as 1.73 ng mL−1 of 8-OHdG can be detected. Con-
sidering the cut-off value of 8-OHdG for healthy adults is 
20–40 ng mL−1, our approach is, therefore, suitable for early 
diagnosis of 8-OHdG.
Conclusion
In conclusion, we have developed a simple approach for 
quantitative detection of 8-OHdG by using a low-cost strip 
and an easily accessible smartphone-based BGM. The cost 
for strips as demonstrated in this work is ~10 USD/pc, of 
which the majority comes from the purchase of 8-OHdG 
antibodies from commercial vendors. The device was able to 
detect 8-OHdG concentrations in PBS as low as 1.73 ng mL−1 
with a dynamic range of 1–200 ng mL−1 in ,1 h. The strip 
was easy to fabricate and convenient to operate, and the 
assay did not require any specialized skills or sophisticated 
instrument. In addition, because of the advantages of the 
BGM, the demonstration of this approach will provide new 
opportunities for the detection of other targets. Our current 
areas of focus are expanding the scope of the strip-BGM 
design to include other targets and even real biomedical 
samples testing, further simplifying the design to eliminate 
the need for target–invertase conjugates to be loaded on con-
jugation pad II enabling various types of target measurements 
and optimizing the experimental conditions to acquire a 
???????? ??????????????????????????????????????????????????????
???
?????????????? ?????????????? ??????????????
???
???
???
???
???
???
Figure 5 RRR for five concentrations of 8-hydroxyguanosine (8-OHdG) invertase 
conjugates used on the conjugation pad II.
Abbreviation: rrr, relative readout ratio.
???
???
???
???
???
???
???
???
??????????????????????????
???
??? ? ??? ? ??? ? ???
? ??? ??? ??? ??? ??? ???????????????? ????
?????????????????? ????
???
???
??? ??? ??? ?????
Figure 6 Detection of 8-Ohdg in buffer based on the smartphone-based blood 
glucose meter.
Notes: The concentration of 8-Ohdg was varied from 0 to 1,000 ng ml−1. Insert: 
linear relationship between Nrr and the logarithm of 8-Ohdg concentration, three 
measurements for each point.
Abbreviations: 8-Ohdg, 8-hydroxy-2′-deoxyguanosine; Nrr, normalized readout 
ratio.
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comparable sensitivity compared with other commercialized 
test kits. The results of these experiments will be reported 
in due course.
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Preparation of auNPs
A well-established citrate reduction method was employed 
to generate AuNPs of various diameters. Different sizes 
of AuNPs produce different reflected color. AuNPs with a 
diameter of ~20 nm intrinsically give a better visibility on 
paper-based strip when accumulated on the test line, and 
therefore we used AuNPs with an average size ~20 nm in 
this work.
Briefly, the hydrogen tetrachloroaurate solution (50 mL, 
0.01% ) was added to a Erlenmeyer flask (250 mL), stirred, 
and brought to the boil on a hotplate. Trisodium citrate 
solution (1 mL, 1%) was added rapidly to the boiling solu-
tion under constant stirring. Gradually, the color changed 
from pale yellow to wine red. After the color change 
ceased, the solution was boiled for another 10 min and 
stirred without heating for another 10 min to complete the 
reduction of the gold chloride. The size of the particles was 
characterized by the Zetasizer after the solution reached 
room temperature.
characterization of auNPs pre- and post-
conjugation
The wine red-colored solution contains AuNPs with a size 
of ~20 nm (Zetasizer, Figure S1A) and its corresponding 
maximum absorbance is exhibited at 520 nm as shown in 
Figure S1B (ultraviolet–visible spectrophotometer). It is well 
known that the strong absorbance at 520 nm is attributed to 
the surface plasmon resonance of AuNPs and the maximum 
absorption peak will be shifted or disappeared if the nano-
particles aggregate or get further modifications.
As a quality control step post-conjugation, the absorbance 
spectrum was again measured and compared with that of 
AuNPs that do not get antibody modifications. A ~3 nm red 
shift was observed as an indication for successful conjuga-
tions (Figure S2).
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Figure S1 characterization of synthesized auNPs and antibody-auNP conjugation. (A) Intensity distribution versus size of auNPs solution (average size, ~20 nm) measure 
by Zetasizer; (B) ultraviolet–visible spectrum of ~20 nm auNPs.
Abbreviations: aU, arbitrary unit; auNPs, gold nanoparticles; rel, relative.
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Figure S2 antibody conjugation of gold nanoparticles produces a red shift in the ultraviolet–visible spectrometer.
Abbreviations: aU, arbitrary unit; N, normalized.
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